- Product
- NA Opp party in unison say ‘it's time for INN prescribing'
- by Kim JiEun Feb 29, 2024 06:03am
- Opposition lawmakers unanimously voiced the need to introduce International Nonproprietary Names (INN) prescribing and the resolution of the unstable drug supply and demand. The National Assembly representatives who attended the 70th Regular General Assembly of the Korean Pharmaceutical Association Delegates that was held at The K Hotel in Se
- Product
- Forxiga return policy in question amid AZ-Daewoong dispute
- by Kang, Hye-Kyung Feb 5, 2024 05:54am
- There was initial confusion among front-line pharmacies regarding the return policy for Forxiga, which is set to be withdrawn from the Korean market. However, it appears that the issue is now being resolved. According to the pharmacy industry sources, there has been a disagreement between AstraZeneca Korea and Daewoong Pharmaceutical re
- Product
- Shortage no more for Saxenda?...'will increase supply'
- by Kang, Hye-Kyung Jan 15, 2024 05:36am
- The supply of Saxenda, which had been showing stock shortages in pharmacies nationwide, is expected to soon increase in Korea. Novo Nordisk announced on the 10th that it has been gradually increasing the supply of Saxenda from this month. The increased supply is expected to reduce the hassle of pharmacies that have been sending patients
- Product
- Saxenda’s shortage prolonged…raises inconveniences
- by Kang, Hye-Kyung Jan 10, 2024 05:42am
- Saxenda's prolonged out-of-stock status is inconveniencing consumers as well as pharmacies. As many patients set New Year’s resolutions of losing weight at the beginning of the year, the lack of Saxenda is causing dissatisfaction among pharmacies and consumers. Even diabetes patients are experiencing the inconvenience of insulin stockout
- Product
- KPDS demands gov. action to end chemotherapy drug shortages
- by Kang, Hye-Kyung Jan 3, 2024 05:40am
- The Korean Pharmacists for Democratic Society (CEO: Hyeong-geun Shin, KPDS) has criticized the government’s system for the stable supply of essential medicines. The KPDS stated on the 28th that “5-fluorouracil, referred to as 5-FU, is a chemotherapy drug used to treat several types of cancers, including colorectal cancer, esophageal c
- Product
- ‘Cutting budget for essential drugs neglects public health'
- by Kang, Hye-Kyung Nov 10, 2023 05:19am
- The Korean Pharmacists for Democratic Society (CEO Hyeong-geun Shin) criticized the full budget for the stable supply of essential national medicines and urged for additional budget allocation. On the 9th, before the National Assembly’s Health and Welfare Committee presented and deliberated on the next year's budget and proceeded with de
- Product
- Investigation into companies refusing to supply animal med.
- by Kim JiEun Oct 6, 2023 05:36am
- The Korean Pharmaceutical Association (Chairman Choi Kwang-hoon) took out its sword against pharmaceutical companies that refused to supply veterinary medicines to pharmacies. Kang Byeong-gu, director of animal medicine at the Korean Pharmaceutical Association, appeared at Seoul Namdaemun Police Station as a complainant on September 26 and
- Product
- Will Insulin being sold out persist for a long time?
- by Kim JiEun Sep 22, 2023 05:41am
- There are signs that the sell-out of insulin preparations will continue for a long time. Some pharmaceutical companies have announced the timing of the resumption of supply, but the wholesale industry predicts that the current crisis will not be resolved in the near future. Novo Nordisk Pharmaceuticals recently announced the schedule for the
- Product
- Phentermine and Saxenda has most reported adverse events
- by Lee, Jeong-Hwan Sep 8, 2023 05:33am
- Phentermine, a psychotropic appetite suppressant, was found to have the highest number of reported adverse events among anti-obesity drugs prescribed in Korea. Saxenda, an anti-obesity drug that was developed by changing the MOA of a diabetes drug, had the second-most reported number of side effects after phentermine. On the 7th, the
- Product
- Hugel’s 'Licellvi Webinar' Successfully Completed
- by 어윤호 Aug 24, 2023 09:00am
- Hugel held a webinar for Thai healthcare professionals (HCPs) on Licellvi (Product name in Korea - Blue Rose Forte). The topic of the webinar was the "Combination of Thread Lifting and Botulinum Toxin", which was attended by over 300 local HCPs. The first speaker, Dr Choi Hosung (Piena Clinic), presented "Exploring the Mid & Lower Face
